We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.74%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$61.7B
AUM Growth
+$546M
(+0.89%)
Cap. Flow
-$4.01B
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
23.47%
Holding
1,295
New
145
Increased
379
Reduced
411
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$218M |
| 2 |
Bank of America
BAC
|
+$205M |
| 3 |
Dollar General
DG
|
+$198M |
| 4 |
Union Pacific
UNP
|
+$197M |
| 5 |
Elevance Health
ELV
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$505M |
| 2 |
Rockwell Automation
ROK
|
+$373M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$294M |
| 4 |
eBay
EBAY
|
+$222M |
| 5 |
TSMC
TSM
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.38% |
| 2 | Healthcare | 15.97% |
| 3 | Financials | 13.78% |
| 4 | Industrials | 11.75% |
| 5 | Communication Services | 10.69% |
Similar funds
QCM
Lazard Asset Management's Q2 2019 Portfolio in Review
As of Q2 2019, Lazard Asset Management held 1,295 positions worth $61.7B, up 0.89% from $61.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $4.01B in Q2 2019, closing 104 positions and reducing 411 holdings. Its most notable exit was Utah Medical Products, an estimated $13.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sabre worth $132M.
- Lazard Asset Management's largest Q2 2019 buy was Sabre: 5,927,264 shares worth $132M.
- Lazard Asset Management added most to Walt Disney in Q2 2019, an estimated $218M increase.
- Lazard Asset Management's biggest Q2 2019 reduction was Wells Fargo, cutting an estimated $505M.
- Lazard Asset Management fully exited Utah Medical Products in Q2 2019, selling an estimated $13.7M.
- Lazard Asset Management's ten largest holdings make up 23% of its $61.7B portfolio in Q2 2019.
- Lazard Asset Management opened 145 new positions and closed 104 in Q2 2019.
- Lazard Asset Management's portfolio value rose 0.89% quarter-over-quarter to $61.7B.
Based on Lazard Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.